Information updates

Novalac Allergy infant formula supply update

30 April 2019

Bayer Australia Ltd (Bayer) has advised ASCIA that Novalac Allergy formula is currently out of stock and ongoing stock shortages will continue over the coming months.  Please note that other Novalac products are unsuitable for infants diagnosed with cow’s milk protein allergy (CMPA).  Information on alternative formulas for infants with CMPA is on the ASCIA website: 

GPs, allergy and paediatric specialists can contact the Bayer Medical Information Team on behalf of patients to discuss compassionate/critical medical cases on 1800 008 757 or by emailing This email address is being protected from spambots. You need JavaScript enabled to view it.

Bayer continues to work as a priority with the global manufacturing partner to increase supply of Novalac Allergy and an update on stock availability will be provided in June.

pdfNovalac Allergy Infant Formula Supply Update April 2019

 Novalac Allergy HCP Supply Update April 2019

Content created 30 April 2019